Phase 2 study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma, the carthadex trial
published in: Haematologica
date of publication: 2019-04-04
language: English
main subject: carfilzomib, dexamethasone, phase II clinical trial
Cites articles 22
Date
Title
Article - wd:Q64111824